Cutaneous Vascular Compromise and Resolution of Skin Barrier Breakdown After Dermal Filler Occlusion-Implementation of Evidence-Based Recommendations Into Real-World Clinical Practice | Canada Hyperbarics Skip to main content
Review Dermatol Surg 2022

Cutaneous Vascular Compromise and Resolution of Skin Barrier Breakdown After Dermal Filler Occlusion-Implementation of Evidence-Based Recommendations Into Real-World Clinical Practice

Loyal J, Hartman N, Fabi S, Butterwick K, Goldman M — Dermatol Surg, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed existing medical literature to create a step-by-step guide for treating skin damage caused by vascular blockages from dermal fillers.

What They Found

The review analyzed 26 articles focusing on vascular occlusions that threaten skin integrity. It confirmed that high-dose, pulsed hyaluronidase is essential for treatment, while other therapies like sodium thiosulfate lacked strong evidence. Hyperbaric oxygen therapy was noted as a potential additional measure to help clear occlusions and repair the skin barrier.

What This Means for Canadian Patients

Canadian patients who experience skin complications from dermal fillers may benefit from a treatment approach that prioritizes high-dose hyaluronidase. While not a primary treatment, hyperbaric oxygen therapy could be considered as an adjunctive option to help improve blood flow and support skin healing in these urgent situations.

Canadian Relevance

No direct Canadian connection identified. Vascular compromise from dermal fillers is not a Health Canada-recognized indication for hyperbaric oxygen therapy.

Study Limitations

As a literature review, this study synthesizes existing evidence and does not present new research or direct patient outcomes.

Was this summary helpful?

Study Details

Study Type Review
Category Ocular / Retinal
Source Pubmed
PubMed ID 35412474
Year Published 2022
Journal Dermatol Surg
MeSH Terms Dermal Fillers; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Skin; Vascular Diseases

Cite This Study

Share

Find a Canadian Clinic Treating Ocular / Retinal

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.